Yoshimi Kikuchi

6.0k citations

170 papers · 4.3k indexed · 1 hit paper · h-index 36

Co-authors: K. Yokoyama Shinichi Oka Hiroyuki Gatanaga Noriki Nio Katsuji Teruya Takeshi Nishijima Masayo Date Hiroshi Matsui
Topics: HIV/AIDS drug development and treatment (50 papers)HIV Research and Treatment (41 papers)HIV/AIDS Research and Interventions (28 papers)
Cited by: Virology Infectious Diseases Emergency Medicine
Journals: SHILAP Revista de lepidopterologíaThe Journal of Cell Biology PLoS ONE
Partner nations: Japan United States United Kingdom

In The Last Decade

Yoshimi Kikuchi

170 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Properties and applications of microbial transglutaminase

2004 480 citations Yoshimi Kikuchi et al. profile →

Peers

Countries citing papers authored by Yoshimi Kikuchi

Since Specialization

Citations

This map shows the geographic impact of Yoshimi Kikuchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshimi Kikuchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshimi Kikuchi more than expected).

Fields of papers citing papers by Yoshimi Kikuchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshimi Kikuchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshimi Kikuchi. The network helps show where Yoshimi Kikuchi may publish in the future.

Co-authorship network of co-authors of Yoshimi Kikuchi

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshimi Kikuchi. A scholar is included among the top collaborators of Yoshimi Kikuchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshimi Kikuchi. Yoshimi Kikuchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of unintended short-term 3.0 g/day amoxicillin and probenecid treatment for early syphilis on patients with HIV-1 infection 2023 ·Therapeutic Advances in Infectious Disease ·(unknown),(unknown),Daisuke Mizushima,Yoshimi Kikuchi,Hiroyuki Gatanaga,Shinichi Oka	1
2	Effect of tenofovir-based HIV pre-exposure prophylaxis against HBV infection in men who have sex with men 2023 ·Hepatology ·Daisuke Mizushima,Misao Takano,Takahiro Aoki,(unknown),Haruka Uemura,Yasuaki Yanagawa,Kôji Watanabe,Hiroyuki Gatanaga,Yoshimi Kikuchi,Shinichi Oka	11
3	Identification of asymptomatic Entamoeba histolytica infection by a serological screening test: A cross-sectional study of an HIV-negative men who have sex with men cohort in Japan 2022 ·PLoS neglected tropical diseases ·Yasuaki Yanagawa,(unknown),Misao Takano,Takahiro Aoki,Daisuke Mizushima,Hiroyuki Gatanaga,Yoshimi Kikuchi,Shinichi Oka,Kenji Yagita,Kôji Watanabe	6
4	Lipocalin 15 in the olfactory mucus is a biomarker for Bowman’s gland activity 2022 ·Scientific Reports ·(unknown),Kenji Kondo,Masayoshi Kobayashi,(unknown),Kazutaka Shimbo,(unknown),Yutaka Maruyama,Yusuke Ihara,(unknown),T Mannen,(unknown),Yoshimi Kikuchi,Yuki Saito,Tatsuya Yamasoba	6
5	Neurocognitive dysfunction and brain FDG-PET/CT findings in HIV-infected hemophilia patients and HIV-infected non-hemophilia patients 2020 ·PLoS ONE ·Koubun Imai,(unknown),(unknown),Aki Watanabe,Ei Kinai,Shinichi Oka,Yoshimi Kikuchi,Satoshi Kimura,(unknown),Misao Takano,Ryogo Minamimoto,Masatoshi Hotta,Kota Yokoyama,Tomoyuki Noguchi,(unknown)	2
6	Seroprevalence of Entamoeba histolytica at a voluntary counselling and testing centre in Tokyo: a cross-sectional study 2020 ·BMJ Open ·Yasuaki Yanagawa,Mami Nagashima,Hiroyuki Gatanaga,Yoshimi Kikuchi,Shinichi Oka,Keiko Yokoyama,(unknown),Kenji Sadamasu,Kôji Watanabe	8
7	High prevalence and incidence of rectal Chlamydia infection among men who have sex with men in Japan 2019 ·PLoS ONE ·Daisuke Mizushima,Misao Takano,Haruka Uemura,Yasuaki Yanagawa,Takahiro Aoki,Kôji Watanabe,Hiroyuki Gatanaga,Yoshimi Kikuchi,Shinichi Oka	13
8	Assessment of HIV prevalence among MSM in Tokyo using self-collected dried blood spots delivered through the postal service 2018 ·BMC Infectious Diseases ·(unknown),Misao Takano,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Yoshimi Kikuchi,Shinichi Oka	26
9	Effect of Tenofovir Disoproxil Fumarate on Incidence of Chronic Kidney Disease and Rate of Estimated Glomerular Filtration Rate Decrement in HIV-1–Infected Treatment-Naïve Asian Patients: Results from 12-Year Observational Cohort 2017 ·AIDS Patient Care and STDs ·(unknown),Takeshi Nishijima,Yohei Kawasaki,(unknown),Yoshikazu Mutoh,Yoshimi Kikuchi,Hiroyuki Gatanaga,Shinichi Oka	43
10	Prognosis of ocular syphilis in patients infected with HIV in the antiretroviral therapy era 2016 ·Sexually Transmitted Infections ·Motoyuki Tsuboi,Takeshi Nishijima,Shigeko Yashiro,Katsuji Teruya,Yoshimi Kikuchi,Naomichi Katai,Shinichi Oka,Hiroyuki Gatanaga	35
11	Brain Magnetic Resonance Imaging Screening Is Not Useful for HIV-1-Infected Patients Without Neurological Symptoms 2014 ·AIDS Research and Human Retroviruses ·Takeshi Nishijima,Hiroyuki Gatanaga,Katsuji Teruya,Tsuyoshi Tajima,Yoshimi Kikuchi,Kanehiro Hasuo,Shinichi Oka	7
12	Is Ritonavir-Boosted Atazanavir a Risk for Cholelithiasis Compared to Other Protease Inhibitors? 2013 ·PLoS ONE ·Yohei Hamada,Takeshi Nishijima,Hirokazu Komatsu,Katsuji Teruya,Hiroyuki Gatanaga,Yoshimi Kikuchi,Shinichi Oka	9
13	Ritonavir-Boosted Darunavir Is Rarely Associated with Nephrolithiasis Compared with Ritonavir-Boosted Atazanavir in HIV-Infected Patients 2013 ·PLoS ONE ·Takeshi Nishijima,Yohei Hamada,Kôji Watanabe,Hirokazu Komatsu,Ei Kinai,Kunihisa Tsukada,Katsuji Teruya,Hiroyuki Gatanaga,Yoshimi Kikuchi,Shinichi Oka	17
14	Preemptive Therapy Prevents Cytomegalovirus End-Organ Disease in Treatment-Naïve Patients with Advanced HIV-1 Infection in the HAART Era 2013 ·PLoS ONE ·Daisuke Mizushima,Takeshi Nishijima,Hiroyuki Gatanaga,Kunihisa Tsukada,Katsuji Teruya,Yoshimi Kikuchi,Shinichi Oka	12
15	Assessment of Antigenemia Assay for the Diagnosis of Cytomegalovirus Gastrointestinal Diseases in HIV-Infected Patients 2013 ·AIDS Patient Care and STDs ·Yohei Hamada,Naoyoshi Nagata,Takuro Shimbo,Toru Igari,Ryo Nakashima,Naoki Asayama,(unknown),Hirohisa Yazaki,Katsuji Teruya,Hiroyuki Gatanaga,Yoshimi Kikuchi,Junichi Akiyama,Norio Ohmagari,Naomi Uemura,Shinichi Oka	6
16	Urinary β ₂ -Microglobulin as a Possible Sensitive Marker for Renal Injury Caused by Tenofovir Disoproxil Fumarate 2006 ·AIDS Research and Human Retroviruses ·Hiroyuki Gatanaga,Natsuo Tachikawa,Yoshimi Kikuchi,Katsuji Teruya,(unknown),Miwako Honda,Junko Tanuma,Hirohisa Yazaki,Akihiro Ueda,Satoshi Kimura,Shinichi Oka	81
17	Leukocytopenia Due to Zidovudine- and Nevirapine-Containing Regimens in Elderly Patients with HIV Infection 2001 ·Japanese Journal of Infectious Diseases ·Yoshihiko Yamamoto,Akira Yasuoka,(unknown),(unknown),Katsuji Teruya,Yoshimi Kikuchi,Natsuo Tachikawa,Shinichi Oka	4
18	Sustained Cytomegalovirus-Specific CD4 ⁺ T Cell Response Associated with Prevention of Recurrence of Cytomegalovirus Retinitis without Secondary Prophylaxis after Highly Active Antiretroviral Therapy in Patients with AIDS 2001 ·AIDS Research and Human Retroviruses ·Mari Tanaka,(unknown),(unknown),Natsuo Tachikawa,Yoshimi Kikuchi,Katsuji Teruya,Akira Yasuoka,Yoshihiro Hirabayashi,Satoshi Kimura,Shinichi Oka	3
19	Mitigation of Hepato-Cellular Injury Caused by HAART with Glycyrrhizin Compound in Patients Co-Infected with HIV and HCV 2000 ·Japanese Journal of Infectious Diseases ·Yoshihiko Yamamoto,Akira Yasuoka,Natsuo Tachikawa,Katsuji Teruya,(unknown),Masazumi Yamaguchi,(unknown),Yoshimi Kikuchi,(unknown),Shinichi Oka	6
20	A Case of Human-Immunodeficiency Virus Infection Related Mycobacterium tuberculosis with Atypical Clinical Features 1991 ·Kansenshogaku zasshi ·Yoshimi Kikuchi,Shinichi Oka,Mieko Goto,Hajime Goto,Satoshi Kimura,Keiko Mitamura,Kazuyuki Shimada	1

About Yoshimi Kikuchi

Yoshimi Kikuchi is a scholar working on Virology, Infectious Diseases and Emergency Medicine, having authored 170 papers that have together received 4.3k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (50 papers), HIV Research and Treatment (41 papers) and HIV/AIDS Research and Interventions (28 papers). The work is most often cited by research in Virology (471 citations), Infectious Diseases (1.3k citations) and Emergency Medicine (525 citations). Yoshimi Kikuchi has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include K. Yokoyama, Shinichi Oka, Hiroyuki Gatanaga, Noriki Nio, Katsuji Teruya, Takeshi Nishijima, Masayo Date, Hiroshi Matsui, Shigeki Mizuno and Kunihisa Tsukada. Their work appears in journals such as SHILAP Revista de lepidopterología, The Journal of Cell Biology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact